Cluster Health & Mission Cancer Brokerage Event

28 Sept 2026 | Brussels, Belgium

Register
Register
Register

Project cooperationUpdated on 4 September 2026

Preclinical Research and Development of Novel Anticancer Therapeutics

Associate professor, Head of the Department at Faculty of Pharmacy, Comenius University Bratislava

Bratislava, Slovakia

About

Research groups at the Faculty of Pharmacy, Comenius University Bratislava, offer complementary expertise covering multiple stages of the preclinical drug discovery and development process, from rational drug design and computational modelling to synthesis, formulation, and pharmacological evaluation of promising drug candidates.

Our expertise and research capabilities include:

  • rational drug design and molecular modelling;

  • quantitative structure–activity relationship (QSAR) studies;

  • virtual combinatorial library design and in silico screening;

  • ADME/Tox prediction and profiling;

  • structure-based drug design and lead optimization;

  • synthesis and characterization of promising drug candidates;

  • in vitro screening and biological evaluation;

  • development of drug delivery systems and carriers;

  • pharmaceutical formulation and drug delivery;

  • pharmacological evaluation of novel drug candidates.

These capabilities can be combined according to the specific needs of a collaborative project, enabling our research teams to contribute to different stages of the preclinical development of novel anticancer therapeutics.

Topic

  • Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
  • Digital health and AI: HORIZON-HLTH-2027-02-TOOL-01-two-stage Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases

Type

  • Partner seeks Consortium/Coordinator

Organisation

Similar opportunities